Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa D Edwards

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Respiratory Medicine|March 8, 2011
Evaluation of exhaled breath condensate pH as a biomarker for COPDWilliam MacNee, Stephen I Rennard, John F Hunt, et al.
The Journal of Allergy and Clinical Immunology|October 13, 2006
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthmaEugene R Bleecker, Steven W Yancey, Leslie A Baitinger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 25, 2003
Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhalerKetan Sheth, Jonathan A Bernstein, William R Lincourt, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice dailyWilliam Busse, Steven M Koenig, John Oppenheimer, et al.
Academic Radiology|March 12, 2011
Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohortHester A Gietema, Nestor L Müller, Paola V Nasute Fauerbach, et al.
The Journal of Pediatrics|August 30, 2005
Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthmaNancy K Ostrom, Bruce A Decotiis, William R Lincourt, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2010
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary diseaseSreekumar G Pillai, Xiangyang Kong, Lisa D Edwards, et al.
Respiratory Medicine|May 18, 2010
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohortMartijn A Spruit, Michael L Watkins, Lisa D Edwards, et al.
COPD|April 19, 2011
Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPDAnnelyse Duvoix, Elena Miranda, Juan Perez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 31, 2013
CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomesElisabeth A P M Romme, John T Murchison, Lisa D Edwards, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Respiratory Medicine|March 8, 2011
Evaluation of exhaled breath condensate pH as a biomarker for COPDWilliam MacNee, Stephen I Rennard, John F Hunt, et al.
The Journal of Allergy and Clinical Immunology|October 13, 2006
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthmaEugene R Bleecker, Steven W Yancey, Leslie A Baitinger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 25, 2003
Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhalerKetan Sheth, Jonathan A Bernstein, William R Lincourt, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice dailyWilliam Busse, Steven M Koenig, John Oppenheimer, et al.
Academic Radiology|March 12, 2011
Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohortHester A Gietema, Nestor L Müller, Paola V Nasute Fauerbach, et al.
The Journal of Pediatrics|August 30, 2005
Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthmaNancy K Ostrom, Bruce A Decotiis, William R Lincourt, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2010
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary diseaseSreekumar G Pillai, Xiangyang Kong, Lisa D Edwards, et al.
Respiratory Medicine|May 18, 2010
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohortMartijn A Spruit, Michael L Watkins, Lisa D Edwards, et al.
COPD|April 19, 2011
Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPDAnnelyse Duvoix, Elena Miranda, Juan Perez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 31, 2013
CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomesElisabeth A P M Romme, John T Murchison, Lisa D Edwards, et al.
Pageof 5